US42226K1051 - REIT

Overall **HR** gets a fundamental rating of **2** out of 10. We evaluated **HR** against 129 industry peers in the **Diversified REITs** industry. **HR** may be in some trouble as it scores bad on both profitability and health. **HR** is valued expensive and it does not seem to be growing.

In the past year **HR** has reported negative net income.

Industry Rank | Sector Rank | ||
---|---|---|---|

ROA | -2.23% | ||

ROE | -4.13% | ||

ROIC | 0.35% |

ROA(3y)-0.18%

ROA(5y)0.14%

ROE(3y)-0.2%

ROE(5y)0.39%

ROIC(3y)1.01%

ROIC(5y)1.4%

Looking at the **Operating Margin**, with a value of **4.04%**, **HR** is doing worse than **90.55%** of the companies in the same industry.

With a **Gross Margin** value of **62.76%**, **HR** is not doing good in the industry: **66.14%** of the companies in the same industry are doing better.

In the last couple of years the **Gross Margin** of **HR** has declined.

Industry Rank | Sector Rank | ||
---|---|---|---|

OM | 4.04% | ||

PM (TTM) | N/A | ||

GM | 62.76% |

OM growth 3Y-43.5%

OM growth 5Y-29.46%

PM growth 3YN/A

PM growth 5YN/A

GM growth 3Y-3.25%

GM growth 5Y-1.68%

With a Return on Invested Capital (ROIC) below the Cost of Capital (WACC), **HR** is destroying value.

Compared to 1 year ago, **HR** has about the same amount of shares outstanding.

Compared to 5 years ago, **HR** has more shares outstanding

Compared to 1 year ago, **HR** has a worse debt to assets ratio.

Based on the Altman-Z score of **0.43**, we must say that **HR** is in the distress zone and has some risk of bankruptcy.

Looking at the **Altman-Z score**, with a value of **0.43**, **HR** is doing worse than **61.42%** of the companies in the same industry.

The Debt to FCF ratio of **HR** is **28.39**, which is on the high side as it means it would take **HR**, **28.39** years of fcf income to pay off all of its debts.

With a decent **Debt to FCF ratio** value of **28.39**, **HR** is doing good in the industry, outperforming **64.57%** of the companies in the same industry.

Looking at the **Debt to Equity ratio**, with a value of **0.74**, **HR** is in the better half of the industry, outperforming **73.23%** of the companies in the same industry.

Industry Rank | Sector Rank | ||
---|---|---|---|

Debt/Equity | 0.74 | ||

Debt/FCF | 28.39 | ||

Altman-Z | 0.43 |

ROIC/WACC0.06

WACC6.19%

A Current Ratio of **0.47** indicates that **HR** may have some problems paying its short term obligations.

The **Current ratio** of **HR** (**0.47**) is worse than **88.19%** of its industry peers.

A Quick Ratio of **0.47** indicates that **HR** may have some problems paying its short term obligations.

Industry Rank | Sector Rank | ||
---|---|---|---|

Current Ratio | 0.47 | ||

Quick Ratio | 0.47 |

The earnings per share for **HR** have decreased strongly by **-82.61%** in the last year.

Looking at the last year, **HR** shows a very strong growth in **Revenue**. The Revenue has grown by **44.09%**.

Measured over the past years, **HR** shows a quite strong growth in **Revenue**. The Revenue has been growing by **14.05%** on average per year.

EPS 1Y (TTM)-82.61%

EPS 3YN/A

EPS 5YN/A

EPS Q2Q%-77.27%

Revenue 1Y (TTM)44.09%

Revenue growth 3Y22.06%

Revenue growth 5Y14.05%

Sales Q2Q%-6.45%

The **Earnings Per Share** is expected to grow by **10.28%** on average over the next years. This is quite good.

EPS Next Y-72.13%

EPS Next 2Y17.54%

EPS Next 3Y10.28%

EPS Next 5YN/A

Revenue Next Year-5.68%

Revenue Next 2Y-2.62%

Revenue Next 3Y-1%

Revenue Next 5YN/A

The Revenue growth rate is decreasing: in the next years the growth will be less than in the last years.

The **Price/Earnings Ratio** is negative for **HR**. In the last year negative earnings were reported.

Besides the negative Price/Earnings Ratio, also the **Forward Price/Earnings Ratio** is negative for **HR**. No positive earnings are expected for the next year.

Industry Rank | Sector Rank | ||
---|---|---|---|

PE | N/A | ||

Fwd PE | N/A |

Based on the **Price/Free Cash Flow** ratio, **HR** is valued a bit cheaper than 65.35% of the companies in the same industry.

Industry Rank | Sector Rank | ||
---|---|---|---|

P/FCF | 34.83 | ||

EV/EBITDA | 14.35 |

PEG (NY)N/A

PEG (5Y)N/A

EPS Next 2Y17.54%

EPS Next 3Y10.28%

Compared to an average industry **Dividend Yield** of **5.79**, **HR** pays a better dividend. On top of this **HR** pays more dividend than 81.89% of the companies listed in the same industry.

Compared to an average S&P500 **Dividend Yield** of **2.22**, **HR** pays a better dividend.

Industry Rank | Sector Rank | ||
---|---|---|---|

Dividend Yield | 7.03% |

The dividend of **HR** decreases each year by **-14.26%**.

Dividend Growth(5Y)-14.26%

Div Incr Years0

Div Non Decr Years0

The earnings of **HR** are negative and hence is the payout ratio. **HR** will probably not be able to sustain this dividend level.

DP-167.7%

EPS Next 2Y17.54%

EPS Next 3Y10.28%

**HEALTHCARE REALTY TRUST INC**

NYSE:HR (10/8/2024, 8:04:00 PM)

After market: 17.13 0 (0%)**17.13**

**-0.26 (-1.5%) **

Chartmill FA Rating

GICS SectorReal Estate

GICS IndustryGroupEquity Real Estate Investment Trusts (REITs)

GICS IndustryDiversified REITs

Earnings (Last)

Earnings (Next)

Inst Owners

Inst Owner Change

Ins Owners

Ins Owner Change

Market Cap6.22B

Analysts

Price Target

Dividend

Industry Rank | Sector Rank | ||
---|---|---|---|

Dividend Yield | 7.03% |

Dividend Growth(5Y)

DP

Div Incr Years

Div Non Decr Years

Ex-Date

Surprises & Revisions

EPS beat(2)

Avg EPS beat(2)

Min EPS beat(2)

Max EPS beat(2)

EPS beat(4)

Avg EPS beat(4)

Min EPS beat(4)

Max EPS beat(4)

EPS beat(8)

Avg EPS beat(8)

EPS beat(12)

Avg EPS beat(12)

EPS beat(16)

Avg EPS beat(16)

Revenue beat(2)

Avg Revenue beat(2)

Min Revenue beat(2)

Max Revenue beat(2)

Revenue beat(4)

Avg Revenue beat(4)

Min Revenue beat(4)

Max Revenue beat(4)

Revenue beat(8)

Avg Revenue beat(8)

Revenue beat(12)

Avg Revenue beat(12)

Revenue beat(16)

Avg Revenue beat(16)

PT rev (1m)

PT rev (3m)

EPS NQ rev (1m)

EPS NQ rev (3m)

EPS NY rev (1m)

EPS NY rev (3m)

Revenue NQ rev (1m)

Revenue NQ rev (3m)

Revenue NY rev (1m)

Revenue NY rev (3m)

Valuation

Industry Rank | Sector Rank | ||
---|---|---|---|

PE | N/A | ||

Fwd PE | N/A | ||

P/S | |||

P/FCF | |||

P/OCF | |||

P/B | |||

P/tB | |||

EV/EBITDA |

EPS(TTM)

EY

EPS(NY)

Fwd EY

FCF(TTM)

FCFY

OCF(TTM)

OCFY

SpS

BVpS

TBVpS

PEG (NY)N/A

PEG (5Y)N/A

Profitability

Industry Rank | Sector Rank | ||
---|---|---|---|

ROA | -2.23% | ||

ROE | -4.13% | ||

ROCE | |||

ROIC | |||

ROICexc | |||

ROICexgc | |||

OM | 4.04% | ||

PM (TTM) | N/A | ||

GM | 62.76% | ||

FCFM |

ROA(3y)

ROA(5y)

ROE(3y)

ROE(5y)

ROIC(3y)

ROIC(5y)

ROICexc(3y)

ROICexc(5y)

ROICexgc(3y)

ROICexgc(5y)

ROCE(3y)

ROCE(5y)

ROICexcg growth 3Y

ROICexcg growth 5Y

ROICexc growth 3Y

ROICexc growth 5Y

OM growth 3Y

OM growth 5Y

PM growth 3Y

PM growth 5Y

GM growth 3Y

GM growth 5Y

F-Score

Asset Turnover0.11

Health

Industry Rank | Sector Rank | ||
---|---|---|---|

Debt/Equity | 0.74 | ||

Debt/FCF | |||

Debt/EBITDA | |||

Cap/Depr | |||

Cap/Sales | |||

Interest Coverage | |||

Cash Conversion | |||

Profit Quality | |||

Current Ratio | 0.47 | ||

Quick Ratio | 0.47 | ||

Altman-Z |

F-Score

WACC

ROIC/WACC

Cap/Depr(3y)

Cap/Depr(5y)

Cap/Sales(3y)

Cap/Sales(5y)

Profit Quality(3y)

Profit Quality(5y)

High Growth Momentum

Growth

EPS 1Y (TTM)-82.61%

EPS 3YN/A

EPS 5Y

EPS Q2Q%

EPS Next Y-72.13%

EPS Next 2Y

EPS Next 3Y

EPS Next 5Y

Revenue 1Y (TTM)44.09%

Revenue growth 3Y22.06%

Revenue growth 5Y

Sales Q2Q%

Revenue Next Year

Revenue Next 2Y

Revenue Next 3Y

Revenue Next 5Y

EBIT growth 1Y

EBIT growth 3Y

EBIT growth 5Y

EBIT Next Year

EBIT Next 3Y

EBIT Next 5Y

FCF growth 1Y

FCF growth 3Y

FCF growth 5Y

OCF growth 1Y

OCF growth 3Y

OCF growth 5Y